Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LifeMax Laboratories
LifeMax Laboratories
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
CP Wire
Mon, 08/27/18 - 09:54 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
Mon, 08/27/18 - 09:12 am
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
